A
Akari Therapeutics - ADR (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics - ADR (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD0.48
- USD0.49
- USD0.44
- USD1.73
- -40.30%
- --
- 114.94k
- 357.63k
- 16M
- 0.42
- -66.00%
Stock News
yesterday
‘Stranger Things’ has made at least $1 billion for Netflix already. Now Season 5 could deliver another $200 million.
MarketWatch
yesterday
Students pursuing these 11 degrees will be eligible to take out up to $200,000 in federal loans under new borrowing limits
CNBC
yesterday
A Hearty Helping for the Holidays: Republic Services Distributes 1,000 Turkeys Across Tennessee
Yahoo
yesterday
Workday shares sink on subscription revenue guidance concerns
CNBC